The motor symptoms of Parkinson's disease (PD) are linked to abnormally correlated and coherent activity in the cortex and subthalamic nucleus (STN). However, in parkinsonian mice we found that cortico-STN transmission strength had diminished by 50%-75% through loss of axo-dendritic and axo-spinous synapses, was incapable of long-term potentiation, and less effectively patterned STN activity. Optogenetic, chemogenetic, genetic, and pharmacological interrogation suggested that downregulation of cortico-STN transmission in PD mice was triggered by increased striato-pallidal transmission, leading to disinhibition of the STN and increased activation of STN NMDA receptors. Knockdown of STN NMDA receptors, which also suppresses proliferation of GABAergic pallido-STN inputs in PD mice, reduced loss of cortico-STN transmission and patterning and improved motor function. Together, the data suggest that loss of dopamine triggers a maladaptive shift in the balance of synaptic excitation and inhibition in the STN, which contributes to parkinsonian activity and motor dysfunction.
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In Brief Chu et al. report that, following loss of dopamine, activation of subthalamic nucleus (STN) NMDA receptors triggers a maladaptive reduction in cortico-STN transmission.
INTRODUCTION
The glutamatergic subthalamic nucleus (STN) is a key element of the cortico-basal ganglia-thalamo-cortical loop, a brain circuit critical for movement control and a major site of dysfunction in psychomotor disorders such as Parkinson's disease (PD) and Huntington's disease (Albin et al., 1989) . The STN is a component of two pathways that facilitate the initiation, execution, and termination of appropriate actions through elevation of GABAergic basal ganglia output: the hyperdirect pathway, where cortical excitation is relayed to the output nuclei by the STN, and the indirect pathway, which traverses the striatum, external globus pallidus (GPe), and STN (Albin et al., 1989; Baunez et al., 1995; Kita and Kita, 2011; Kravitz et al., 2010; Mink and Thach, 1993; Nambu et al., 2002; Tecuapetla et al., 2016) . Increased cortical driving and hyperactivity of the STN have been linked to akinesia, bradykinesia, and rigidity in PD and its models (Galvan and Wichmann, 2008; Jenkinson and Brown, 2011) , whereas loss or reduction of STN activity is associated with hyperkinesia and dyskinesia in hemiballism and Huntington's disease (Albin et al., 1989; Callahan and Abercrombie, 2015; Hamada and DeLong, 1992) . Excessively coherent and correlated cortico-STN activity, particularly in the b band, is also correlated with parkinsonian motor symptoms (Delaville et al., 2015; Blumenfeld and Bront€ e-Stewart, 2015; Sharott et al., 2014; Shimamoto et al., 2013; Zaidel et al., 2009) . Theoretical studies suggest that cortico-STN transmission contributes not only to pathological STN activity but also to abnormally persistent and widespread b band activity throughout the cortico-basal ganglia-thalamo-cortical loop in PD (Moran et al., 2011; Pavlides et al., 2015) . Indeed, blockade of STN glutamate receptors reduces abnormal STN activity (Tachibana et al., 2011) , and high-frequency deep-brain electrical stimulation in PD has been proposed to exert its therapeutic effects by modifying cortico-STN activity and transmission (Gradinaru et al., 2009; Li et al., 2012; de Hemptinne et al., 2015; Sanders and Jaeger, 2016) .
In acute lesion models of PD, it takes days to weeks for parkinsonian STN activity to develop (Vila et al., 2000; Mallet et al., 2008a) , implying that plasticity triggered by loss of dopamine (e.g., Day et al., 2006; Fan et al., 2012; Gittis et al., 2011) contributes to its emergence. Alterations in the frequency and pattern of GPe-STN inhibition due to elevated striato-pallidal transmission may lead to disinhibited cortical patterning of the STN (Albin et al., 1989; Mallet et al., 2008b; Tachibana et al., 2011; Pavlides et al., 2015) . Increased activation of NMDA receptors (NMDARs) at cortico-STN synapses could therefore promote LTP of cortical inputs (Chu et al., 2015) . Indeed, STN neurons exhibit an increase in the ratio of AMPA receptor (AMPAR) to NMDAR current (Shen and Johnson, 2005) , and GPe-STN synapses proliferate through NMDAR-dependent heterosynaptic plasticity in PD rodents (Chu et al., 2015) . However, in parkinsonian monkeys a decrease in the number of cortico-STN inputs has been reported (Mathai et al., 2015) . Together, these data suggest that cortico-STN transmission may be mediated by fewer but potentially more powerful inputs following loss of dopamine.
The balance of synaptic excitation and inhibition in neuronal networks is critical to their performance and is controlled by long-term and/or homeostatic plasticity (Malenka and Nicoll, 1999; Turrigiano, 2011) . These plasticities optimize information processing and storage under normal conditions but in disease states can produce maladaptive changes, which compromise both network performance and behavior. We therefore tested three hypotheses using the chronic, unilateral, 6-hydroxydopamine (6-OHDA)-lesion mouse model of mid-to late-stage PD:
(1) the properties of cortico-STN synaptic inputs are modified following loss of dopamine; (2) cortico-STN synaptic plasticity is triggered by elevated striato-pallidal transmission, leading to disinhibition of the STN and increased activation of STN NMDARs; and (3) an abnormal balance of cortico-STN excitation relative to GPe-STN inhibition impairs motor function.
RESULTS
Data are reported as median and interquartile range. Boxplots illustrate the median (central line), interquartile range (box), and 10%-90% range (whiskers) of the data. Unpaired and paired non-parametric statistical comparisons were made using the Mann-Whitney U test and the Wilcoxon signed-rank test, respectively. The Holm-Bonferroni method was applied to correct for multiple comparisons. p < 0.05 was considered significant.
The Strength of Cortico-STN Transmission Decreases Following Chronic Loss of Dopamine
The physiological properties of motor cortico-STN transmission were compared in brain slices from 6-OHDA-injected, dopamine-depleted, and vehicle-injected dopamine-intact mice using optogenetic stimulation and patch-clamp recording. Cortico-STN excitatory postsynaptic currents (EPSCs) were evoked at À80 mV to isolate AMPAR-mediated transmission (Chu et al., 2015) . The amplitude of cortico-STN transmission was diminished across a range of stimulation intensities in slices from dopamine-depleted mice relative to control mice (e.g., EPSC amplitude at 2.6 mW/mm 2 , vehicle = 488, 405-552 pA, n = 18 neurons, 3 mice; 6-OHDA = 129, 103-242 pA, n = 16 neurons, 3 mice; p < 0.05; Figures 1A-1D ). The ratio of EPSC2 (stimulated 100 ms after EPSC1) to EPSC1 was similar in slices from dopamine-depleted versus dopamine-intact mice (e.g., EP-SC2:EPSC1 at 2.6 mW/mm 2 , vehicle = 0.81, 0.61-0.86, n = 18 neurons, 3 mice; 6-OHDA = 0.75, 0.54-1.07, n = 16 neurons, 3 mice; p > 0.05; Figures 1E and 1F ), arguing that a lower initial probability of transmission was not responsible for reduced cortico-STN transmission. Asynchronous cortico-STN transmission, optogenetically evoked in the presence of Sr
2+
, was compared in slices from dopamine-depleted versus dopamineintact mice. Both the frequency (vehicle = 14.9, 7.8-24.9 Hz, n = 24 neurons, 4 mice; 6-OHDA = 5.9, 3.8-10.6 Hz, n = 19 neurons, 4 mice; p < 0.05; Figures 1G and 1H ) and the amplitude (vehicle = 12.6, 10.8-19 .6 pA, n = 24 neurons, 4 mice; 6-OHDA = 10.8, 9.7-12.0 pA, n = 19 neurons, 4 mice; p < 0.05; Figures 1G and 1I) of asynchronous transmission were reduced following dopamine depletion. Together, these data suggest that, following the loss of dopamine, the strength of AMPARmediated cortico-STN transmission decreases, largely through a reduction in the number of functional inputs.
The Number of Cortico-STN Inputs Decreases Following Loss of Dopamine
To determine the impact of dopamine depletion on cortico-STN innervation, immersion-fixed brain slices from 6-OHDA and vehicle-injected mice were processed for the immunohistochemical detection of vesicular glutamate transporter type 1 (vGluT1), a predominantly cortical axon terminal marker that is not expressed by subcortical afferents of the STN (Barroso-Chinea et al., 2008; Wang and Morales, 2009) . The densities of vGluT1-immunoreactive puncta in the STN were then determined stereologically (West, 1999) . Consistent with non-human primate data (Mathai et al., 2015) , the density of vGluT1-immunoreactive puncta was lower in slices from dopamine-depleted versus dopamine-intact mice (vehicle = 19.2, 15.1-23.7 Cortico-STN axon terminals synapse with distal dendrites and to a lesser degree with dendritic spines (Bevan et al., 1995) . To determine whether dopamine depletion produced corresponding postsynaptic alterations, the morphologies of Golgi-impregnated STN neurons in tissue from perfuse-fixed 6-OHDA-injected and vehicle-injected mice were compared ( Figures 2D-2K ). Three-dimensional, morphometric analysis confirmed several alterations in dopamine-depleted mice: (1) there were fewer dendritic branches at distances greater than 30 mm from the soma (e.g., dendrites intersecting a 50 mm diameter sphere centered on the soma: vehicle = 5, 4-6; n = 26 neurons, 3 mice; 6-OHDA = 3, 2-4; n = 26 neurons, 3 mice; p < 0.05; Figures 2D-2F and 2H); (2) the total dendritic length was shorter (vehicle = 421, 307-558 mm; n = 26 neurons, 3 mice; 6-OHDA = 294, 261-375 mm; n = 26 neurons, 3 mice; p < 0.05; Figures 2D-2F and 2I); and (3) there were fewer dendritic spines (vehicle = 21, n = 26 neurons, 3 mice; (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) n = 26 neurons, 3 mice; p < 0.05; Figures 2G, 2J, and 2K) . Together these data demonstrate that both cortico-STN axon terminals and their postsynaptic targets were eliminated following loss of dopamine.
The Physiological Properties of Cortico-STN Transmission Are Altered Following Loss of Dopamine Plasticity and pathological processes can modulate the strength and nature of glutamatergic transmission through changes in GluA2 AMPAR subunit expression (Isaac et al., 2007; Jonas et al., 1994; Liu and Savtchouk, 2012) . The pharmacological and biophysical properties of cortico-STN synapses were therefore assessed. Cortico-STN EPSCs optogenetically evoked at À80 mV were relatively sensitive to the Ca 2+ -permeable AMPAR antagonist 1-Naphthyl acetyl spermine trihydrochloride (Naspm; 100 mM) in slices from 6-OHDA-injected mice (Naspm inhibition: vehicle = 38.7, 24.5%-42.5%; n = 8 neurons, 3 mice; 6-OHDA = 57.4, 53.3%-60.8%; n = 7 neurons, 4 mice; p < 0.05; Figures 3A and 3B), implying a reduction in GluA2 expression. Consistent with reduced GluA2 expression, AMPAR-mediated cortico-STN transmission in the presence of the NMDAR antagonist D-APV (50 mM) was faster (t decay : vehicle = 6.8, 4.6-7.8 ms; n = 18 neurons, 3 mice; 6-OHDA = 4.0, 3.3-5.0 ms; n = 16 neurons, 3 mice; p < 0.05; Figures 3C and 3D ), and inward rectification was stronger in 6-OHDA-treated mice (EPSC amplitude at À80 mV/+40 mV: vehicle = 1.7, 1.3-2.7; n = 30 neurons, 7 mice; 6-OHDA = 2.4, 1.9-3.5; n = 31 neurons, 6 mice; p < 0.05; Figures  3C and 3E ). Together, these data suggest that, following loss of dopamine, cortico-STN AMPAR-mediated transmission undergoes associated molecular and biophysical alterations. No change in AMPAR:NMDAR ratio was observed ( Figure S1 ). Repeated optogenetic driving of cortico-STN transmission in dopamine-intact mouse brain slices can lead to NMDAR-dependent LTP, most likely through insertion of postsynaptic AMPAR subunits (Chu et al., 2015) . Loss of dopamine prevents or alters the induction of synaptic plasticity in the striatum (Gerfen and Surmeier, 2011) . To determine whether dopamine depletion affects LTP in the STN, cortico-STN EPSCs were compared 5 min before and 35-40 min after an optogenetic stimulation protocol shown to induce LTP (1 ms light pulses delivered at 50 Hz for 300 ms, with stimulus trains repeated 30 times at 0.2 Hz; Chu et al., 2015) . LTP was induced in slices from dopamine-intact (median EPSC amplitude post-induction relative to pre-induction: vehicle = 134.5, 108.3%-151.5%; n = 7 neurons, 5 mice; p < 0.05; Figure 3F ), but not dopamine-depleted mice (6-OHDA = 79.7, 54.9%-90.5%; n = 10 neurons, 5 mice; p > 0.05; Figure 3G ). LTP was not rescued by application of 0.5-1.0 mM dopamine (99.7, 82.2%-102.8%; n = 8 neurons, 4 mice; p > 0.05; Figure 3H ). Thus, the capacity for LTP of cortico-STN transmission is impaired in PD mice.
Cortico-STN Patterning Is Diminished Following Loss of Dopamine
To determine the impact of dopamine depletion on cortico-STN b band patterning, the effects of optogenetic stimulation (15 Hz in 1 ms pulses for 1 s at an intensity of 1.0 mW/mm 2 ) of cortico-STN axon terminals on STN activity were compared in slices from 6-OHDA-and vehicle-injected mice. b band stimulation of each STN neuron was repeated three times at a frequency of 0.033 Hz. STN neurons were recorded in the loose-seal, cellattached configuration to minimize perturbation of their firing. The number of cortically generated action potentials (synaptic drive) was defined using peristimulus time histograms (PSTHs) as those exceeding the mean plus 3 SD of action potential counts in the 2 s preceding stimulation. The spontaneous firing of STN neurons (Atherton et al., 2008) decreased in frequency (vehicle = 11.6, 8.2-13.9 Hz; n = 17 neurons, 4 mice; 6-OHDA = 2.7, 0-8.5 Hz; n = 17 neurons, 4 mice; p < 0.05; Figures 4A-4E) and regularity (CV: vehicle = 0.12, 0.10-0.18; n = 16 neurons, 4 mice; 6-OHDA = 0.43, 0.16-0.58; n = 10 neurons, 4 mice; p < 0.05; Figures 4A-4E ) following loss of dopamine, consistent with previous observations (Wilson et al., 2006; Zhu et al., 2002) . In neurons from 6-OHDA-injected mice, (1) the number of cortically generated action potentials was lower (synaptic drive: vehicle = 31, 20-41; n = 17 neurons, 4 mice; 6-OHDA = 15, 9-23; n = 17 neurons, 4 mice; p < 0.05; and (2) the latencies and interquartile ranges of latencies of cortically stimulated action potentials were increased (latency: vehicle = 3.7, 2.5-6.3 ms; n = 17 neurons, 4 mice; 6-OHDA = 18.2, 11.6-31.6 ms; n = 17 neurons, (Chu et al., 2015) . Together, these data confirm that cortico-STN patterning is greatly diminished following chronic loss of dopamine and that AMPAR-mediated transmission largely mediates cortico-STN patterning in both dopamine-depleted and dopamine-intact mice.
Chronic Chemogenetic Elevation of Striato-Pallidal Transmission In Vivo Leads to a Reduction in Cortico-STN Transmission
Following loss of dopamine, elevated D2-striatal projection neuron (D2-SPN) transmission to the GPe leads to disinhibition and altered patterning of the STN Mallet et al., 2006 Mallet et al., , 2008b . To determine whether elevated D2-SPN-GPe transmission is sufficient for cortico-STN input loss, dopamine-intact, transgenic adora2A-rM3Ds-mCherry mice (Figures 5A-5C) were administered clozapine-N-oxide (CNO; 1 mg/kg) or vehicle subcutaneously approximately every 12 hr over 2-3 days to chemogenetically activate rM3Ds-mCherry in D2-SPNs (Farrell et al., 2013) and control for injection, respectively. Mice were placed in an open-field chamber, and locomotor activity was monitored for 5 min, 45 min before and 30 min after injection. Data from the first 2 min of activity were analyzed separately to minimize the contribution of exploration due to a novel environment (see Figure S2; c.f. Lemos et al., 2016) . Consistent with an increase in D2-SPN-GPe transmission, chemogenetic activation of rM3Ds in vivo (1) reduced the distance traveled in the open field during minutes 3-5 (e.g., distance traveled day 2: vehicle = 3.94, 1.75-7.76 m; n = 6 mice; CNO = 0.036, 0.02-0.06 m; n = 6 mice; p < 0.05; Figures 5D-5F) and (2) reduced firing of GPe neurons recorded under urethane anesthesia during cortical slow-wave activity (mean frequency of GPe activity: 20 min pre-CNO = 19.4, 13.7-27.3 Hz; >30 min post-CNO = 14.8, 7.7-24.0 Hz; n = 28 neurons, 4 mice; p < 0.05; Figures 5G and 5H ). Furthermore, chemogenetic activation of rM3Ds ex vivo (10 mM CNO) elevated the frequency, but not the amplitude, of GABA A receptor-mediated miniature IPSCs (mIPSCs) recorded in GPe neurons in the presence of 1 mM tetrodotoxin (frequency: control = 10.3, 9.2-13.1 Hz; n = 6 neurons, 2 mice; CNO = 20.4, 14.1-24.5 Hz; n = 7 neurons, 2 mice; p < 0.05; amplitude: control = 35.2, 32.0-41.5 pA; n = 6 neurons, 2 mice; CNO = 34.1, 27.0-37.3 pA; n = 7 neurons, 2 mice; p > 0.05; Figures 5I-5K ). However, chemogenetic activation of rM3Ds ex vivo did not increase the excitability of D2-SPNs ( Figure S2 ), arguing that an increase in the probability of D2-SPN transmission is sufficient for akinesia (c.f. Lemos et al., 2016) . Chemogenetic activation of D2-SPN rM3Ds for 2-3 days in vivo led to a reduction in the density of vGluT1-immunoreactive cortico-STN axon terminals (vehicle = 38.6, 30.7-46 .9 million/mm 3 ; n = 35 samples, 3 mice; CNO = 22.4, 19.6-27.2 million/mm 3 ; n = 35 samples, 3 mice; p < 0.05; Figures 5L-5N ) and to a reduction in the strength of optogenetically stimulated cortico-STN transmission (e.g., amplitude at 2.6 mW/mm 2 : vehicle = 528.8, 509.3-813.2 pA, n = 17 neurons, 2 mice; CNO = 163.8, 105.3-236.5 pA; n = 24 neurons, 2 mice; p < 0.05; Figures 5O and 5P) relative to vehicle-injected mice. Together, these data argue that elevated D2-SPN-GPe transmission is sufficient to trigger downregulation of cortico-STN transmission in dopamine-intact mice.
Excessive Activation of STN NMDARs Triggers Downregulation of Cortico-STN Transmission Following
Loss of Dopamine The experiments described above suggest that elevated inhibition of the GPe by D2-SPNs is sufficient for downregulation of cortico-STN transmission. In 6-OHDA-injected rodents, which exhibit similarly elevated D2-SPN-GPe transmission and STN disinhibition (Mallet et al., 2006 (Mallet et al., , 2008b , increased activation of STN NMDARs triggers proliferation of GPe-STN synapses Chu et al., 2015) . To determine whether STN NMDARs regulate the number of cortico-STN synapses, transgenic mice (Tsien et al., 1996) to control for AAV injection and to knockdown STN NMDARs, respectively, as described previously (Chu et al., 2015) . 6-OHDA or vehicle was also injected into the medial forebrain bundle in the same surgery. Knockdown of STN NMDARs with this approach has been validated recently (Chu et al., 2015) . Several weeks later, brain slices from these mice were prepared, immersion fixed, and processed for vGluT1 immunohistochemistry. In eGFP-expressing, NMDAR-intact mice, dopamine depletion led to a decrease in vGluT1 expressing cortico-STN axon terminal density relative to vehicle-injected control mice, consistent with the above data (vGluT1 density: vehicle, eGFP = 17. Figures 6E-6G ). Together these data suggest that, following dopamine depletion, increased activation of STN NMDARs, presumably due to disinhibition, triggers cortico-STN input loss.
To determine the impact of NMDAR knockdown on the physiological properties of cortico-STN transmission, the cohorts of mice described above were additionally injected with an AAVexpressing ChR2(H134R)-eYFP in the motor cortex. Cortico-STN inputs were then interrogated optogenetically ex vivo in the presence of Sr 2+ to assess quantal properties, as described above. Neurons expressing eGFP or cre-eGFP were targeted for patch-clamp recording using epifluorescent imaging. Consistent with the above data, loss of dopamine led to a reduction in the frequency and amplitude of optogenetically evoked, asynchronous cortico-STN transmission in NMDAR-intact STN neurons (frequency: vehicle, eGFP = 13.6, 9.3-18.9 Hz; n = 18 neurons, 2 mice; 6-OHDA, eGFP = 6.1, 5.2-8.9 Hz; n = 26 neurons, 4 mice; p < 0.05; amplitude: vehicle, eGFP = 12.6, 11.7-13.7 pA; n = 18 neurons, 2 mice; 6-OHDA, eGFP = 10.4, 9.0-11.4 pA; n = 26 neurons, 4 mice; p < 0.05; Figures 6H-6J ). Knockdown Figures 6H and 6I) . However, the amplitude of asynchronous cortico-STN transmission in NMDAR-knockdown, dopamine-depleted mice was modestly lower than in NMDAR-intact, dopamine-intact mice (6-OHDA, cre-eGFP = 9.4, 8.1-12.2 pA; n = 23 neurons, 3 mice; p < 0.05; Figures 6H and 6J) . Thus, knockdown of STN NMDARs increased the frequency of asynchronous cortico-STN AMPAR-mediated transmission and prevented the reduction in the frequency, but not the amplitude, of asynchronous cortico-STN transmission that follows loss of dopamine.
Knockdown of STN NMDARs also largely prevented the loss of cortico-STN synaptic patterning in dopamine-depleted mice ( Figures 6K-6M) . In NMDAR-intact mice, cortico-STN synaptic patterning was reduced by dopamine depletion (synaptic drive: vehicle, eGFP = 34.0, 24.5-37.5; n = 20 neurons, 2 mice; 6-OHDA, eGFP = 11.0, 6.0-26.5; n = 20 neurons, 2 mice; p < 0.05; latency: vehicle, eGFP = 2.9, 2.1-4.2 ms; n = 20 neurons, 2 mice; 6-OHDA, eGFP = 21.0, 10.5-26.5 ms; n = 20 neurons, 2 mice; p < 0.05; interquartile range of latency: vehicle, eGFP = 1.7, 0.6-2.3 ms; n = 20 neurons, 2 mice; 6-OHDA, eGFP = 18.4, 11.9-27.4 ms; n = 20 neurons, 2 mice; p < 0.05; Figures  6K-6M ). In dopamine-depleted mice, knockdown of STN NMDARs increased the strength of cortico-STN patterning relative to mice with intact NMDARs (synaptic drive: 6-OHDA, cre-eGFP = 31, 22.5-40.5; n = 20 neurons, 2 mice; latency: 6-OHDA, cre-eGFP = 7.4, 2.3-11.7 ms; n = 20 neurons, 2 mice; p < 0.05; interquartile range of latency: 6-OHDA, cre-eGFP = 5.5, 0.9-10.2 ms; n = 20 neurons, 2 mice; p < 0.05; Figures  6K-6M ). In dopamine-depleted mice with knockdown of STN NMDARs, cortico-STN synaptic drive was not significantly different from that in dopamine-and NMDAR-intact mice (p > 0.05; Figures 6K and 6L) . However, the latency and range of latency of synaptically generated action potentials were modestly but significantly greater in dopamine-depleted mice with knockdown of STN NMDARs relative to dopamine-and NMDAR-intact mice (p < 0.05; Figures 6K and 6M ). Application of exogenous NMDA ex vivo is sufficient to mimic NMDAR-dependent synaptic and cellular plasticities in the STN of PD (Chu et al., 2015) and Huntington's disease (Atherton et al., 2016) mice. To determine whether NMDAR activation is sufficient to downregulate cortico-STN transmission, brain slices were incubated in 25 mM NMDA for 1 hr, prior to anatomical and electrophysiological measurements. This treatment did not affect the density of STN neurons ( Figure S3 ) and does not abolish their electrophysiological activity (Atherton et al., 2016) , arguing that it is not excitotoxic. In brain slices from vehicle-injected, Tables S1-S3. dopamine-intact mice, NMDAR activation ex vivo reduced both the density of vGluT1 cortico-STN terminals (vGluT1 density: control = 19.5, 15.8-23.6 million/mm 3 ; n = 15 samples, 3 mice; NMDAtreated = 11.9, 9.7-12.9 million/mm 3 ; n = 18 samples, 3 mice; p < 0.05; Figures 7A-7C ) and the amplitude of optogenetically stimulated cortico-STN transmission (amplitude at 2.6 mW/mm 2 : control = 350.3, 254.2-659.4 pA; n = 13 neurons, 3 mice; NMDA-treated = 141.1, 68.1-172.8 pA; n = 13 neurons, 3 mice; p < 0.05; Figures 7G-7I ). However, NMDA incubation ex vivo had no effect on these parameters in brain slices from 6-OHDA-injected mice (vGluT1 density: control = 10.9, 8.9-12.5 million/mm Figures 7J-7L ). These data suggest that (1) NMDAR activation ex vivo was sufficient to downregulate cortico-STN transmission in slices from dopamine-intact mice and (2) in dopamine-depleted mice NMDAR-dependent cortico-STN downregulation in vivo occluded the effect of NMDAR activation ex vivo. NMDAR-dependent downregulation ex vivo was similarly occluded in slices from CNO-treated but not vehicle-treated adora2A-rM3Ds-mCherry mice ( Figure S3 ). Excessive activation of Ca v 1.3 channels contributes to loss of cortico-D2-SPN axospinous synapses following chronic dopamine depletion (Day et al., 2006) . However, cortico-STN downregulation was still observed in dopamine-depleted transgenic Ca v 1.3 channel knockout (Cacna1d À/À ) mice (Platzer et al., 2000 ; Figure S3 ). Together, our data suggest that STN NMDAR activation is sufficient for cortico-STN downregulation in dopamine-depleted mice and in dopamine-intact mice in which D2-SPNs have been chemogenetically activated.
Increasing the Strength of Cortico-STN Transmission Relative to GPe-STN Transmission Ameliorates Parkinsonian Motor Dysfunction
Given that elevated cortical patterning of the STN and STN hyperactivity are linked to motor dysfunction in PD, the combined effects of STN NMDAR knockdown on cortico-STN and GPe-STN transmission (Tables S1-S3) are predicted to impair motor function. To test this prediction, we used the viral-mediated expression strategies described above to manipulate cortico-STN and GPe-STN transmission in unilateral vehicle-and 6-OHDA-injected Grin1 lox/lox mice and then subjected these mice to tests of motor function. In NMDAR-intact mice, dopamine depletion (1) increased the use of the forelimb ipsilateral to the injected hemisphere during the cylinder test (Schallert et al., 2000) (percent ipsilateral forelimb use: eGFP, vehicle = 42.3, 36.0%-45.0%; n = 11 mice; Movie S1; eGFP, 6-OHDA = 78.3, 72.0%-83.5%; n = 7 mice; Movie S2; p < 0.05; Figure 8A ); (2) increased rotational behavior toward the injected hemisphere (percent ipsiversive rotations: eGFP, vehicle = 48.7, 37.4%-71.4%; n = 12 mice; eGFP, 6-OHDA = 100.0, 100.0%-100.0%; n = 10 mice; p < 0.05; Figure 8B ); and (3) reduced distance traveled in the open field (distance traveled in minutes 3-5: eGFP, vehicle = 7.6, 4.9-10.3 m; n = 12 mice; eGFP, 6-OHDA = 2.9, 0.9-3.7 m; n = 10 mice; p < 0.05; Figures 8C and 8D ; c.f. Figure S4) , consistent with hemiparkinsonian motor dysfunction. However, contrary to the above prediction, aspects of motor behavior in NMDAR-knockdown, dopamine-depleted mice were improved relative to NMDAR-intact, dopamine-depleted mice (percent ipsilateral forelimb use: cre-eGFP, 6-OHDA = 57.6, 50.8%-62.5%; n = 9 mice; Movie S3; p < 0.05; Figure 8A ; distance traveled in minutes 3-5 in the open field: cre-eGFP, 6-OHDA = 5.9, 3.6-7.7 m; n = 10 mice; p < 0.05; Figures 8C  and 8D ; c.f. Figure S4 ). However, ipsiversive rotational behavior was not improved (percent ipsiversive rotations: cre-eGFP, 6-OHDA = 96.7, 66.7%-100%; n = 10 mice; p > 0.05; Figure 8B ). Interestingly, the motor behavior of NMDAR knockdown, dopamine-intact mice was not significantly impaired relative to NMDAR-intact, dopamine-intact mice (percent ipsilateral forelimb use: cre-eGFP, vehicle = 38.7, 35.6%-45.3%; n = 6 mice; Movie S4; p > 0.05; Figure 8A ; percent ipsiversive rotations: cre-eGFP, vehicle = 44.2, 33.3%-72.7%; n = 6 mice; p > 0.05; Figure 8B ; distance traveled in minutes 3-5 in the open field: cre-eGFP, vehicle = 7.0, 4.5-9.1 m; n = 6 mice; p > 0.05; Figures  8C and 8D ; c.f. Figure S4 ). Dopamine-depleted mice with NMDAR knockdown restricted to structures overlying the STN exhibited similar ipsilateral forelimb use to dopamine-depleted mice with eGFP expression in the STN (percent ipsilateral forelimb use: cre-eGFP outside STN, 6-OHDA = 82.6, 71.5%-87.5%; n = 5; p > 0.05; Figure S5 ). Taken together, the behavioral data are inconsistent with the view that an increase in the strength of cortico-STN transmission relative to GPe transmission promotes motor dysfunction. Rather, our physiological, anatomical, and behavioral data argue that following loss of dopamine a maladaptive decrease in cortico-STN transmission strength relative to GPe-STN transmission strength (Chu et al., 2015) contributes to impaired movement.
DISCUSSION
A wealth of evidence has suggested that the cortico-STN hyperdirect pathway plays a key role in patterning pathological STN activity in PD. Multiple aspects of parkinsonian cortico-STN activity are associated with motor symptoms, including excessive coherent and correlated activity and burst firing (Delaville et al., 2015; Blumenfeld and Bront€ e-Stewart, 2015; Sharott et al., 2014; Sanders et al., 2013; Shimamoto et al., 2013; Zaidel et al., 2009 ). Furthermore, ''correction'' of parkinsonian cortico-STN activity is correlated with the therapeutic effects of dopamine-based medications and STN deep-brain stimulation (DBS) (Blumenfeld and Bront€ e-Stewart, 2015; Delaville et al., 2015; Eusebio et al., 2012; Tachibana et al., 2011) . Theoretical studies also consistently link the hyperdirect cortico-STN pathway to pathological activity in the STN and wider cortico-basal ganglia thalamo-cortical circuit (Moran et al., 2011; Pavlides et al., 2015) . Indeed, stimulation of cortico-STN axons during STN DBS has been proposed to be particularly critical for therapy (Gradinaru et al., 2009; Li et al., 2012; de Hemptinne et al., 2015; Sanders and Jaeger, 2016) . Because cortico-STN axon terminals exhibit NMDAR-dependent LTP (Chu et al., 2015) , we predicted that parkinsonian cortico-STN activity would both promote and be promoted by this form of plasticity. However, we discovered that cortico-STN transmission strength was profoundly reduced in parkinsonian mice and that the pre-and post-synaptic components of cortico-STN synapses were lost. These data are consistent with loss of cortico-STN synapses in the MPTP-treated non-human primate model of PD and the reduced ''hyperdirect pathway'' response of STN and basal ganglia output neurons following electrical stimulation of the cortex in vivo in dopamine-depleted rodents and monkeys Mathai et al., 2015) . The pharmacological profile, rapid kinetics, and voltage dependence of cortico-STN transmission in parkinsonian mice also suggest a reduction in GluA2 AMPAR subunit expression and therefore an increase in Ca 2+ -permeable AMPAR-mediated transmission (Isaac et al., 2007; Liu and Savtchouk, 2012) . However, despite the loss of lower-conductance GluA2-containing AMPARs, the amplitude of asynchronous cortico-STN EPSCs decreased modestly. NMDAR-dependent LTP of the Tables S1-S3. cortico-STN pathway was also impaired in dopamine-depleted mice and, in contrast to the striatum (Gerfen and Surmeier, 2011) , not rescued by acute dopamine receptor activation. Whether impairment of LTP is due to synapse loss and/or alterations in AMPAR and/or NMDAR expression requires further investigation.
Chronic chemogenetic activation of D2-SPNs in dopamineintact mice was sufficient to downregulate cortico-STN transmission, arguing that elevated striatal inhibition of GPe-STN neurons led to disinhibition of the STN, which triggered cortical input loss. Consistent with this mechanism, chemogenetic activation of D2-SPNs elevated inhibitory transmission to GPe neurons and reduced GPe activity. Thus, in dopamine-intact mice, alterations in circuit activity that mimic those in PD (Mallet et al., 2006) are sufficient for cortico-STN downregulation. In PD models, increased inhibition of GPe-STN neurons (Mallet et al., 2006) and antiphasic GPe and STN activity (Mallet et al., 2008b) increase the probability that synaptic excitation of the STN is unopposed by GABAergic inhibition . Because excessive NMDAR activation triggers loss of glutamatergic synapses in a variety of diseases and brain regions (Andres et al., 2013; Hasbani et al., 2001; Kim et al., 2008; Meller et al., 2008) , we investigated whether NMDARs also underlie downregulation of cortico-STN transmission. In PD mice, knockdown of STN NMDARs largely prevented loss of cortico-STN inputs, transmission, and patterning. Knockdown of STN NMDARs also increased the number of cortico-STN inputs in dopamineintact mice relative to NMDAR-expressing controls (cf. Adesnik et al., 2008; Mu et al., 2015) . Furthermore, activation of STN NMDARs ex vivo was sufficient to reduce cortico-STN axon terminal density and transmission in brain slices from dopamineintact mice. However, this action was occluded in slices from PD mice or chemogenetically activated adora2A-rM3Ds-mCherry mice, consistent with prior NMDAR-triggered cortico-STN downregulation in vivo. Although the responsible signaling elements downstream of STN NMDARs have not been identified, NMDAR-triggered loss of glutamatergic synapses is mediated through enzymes and enzyme complexes including calpain, caspase-3, PP1/PP2, and the ubiquitin-proteasome pathway (Andres et al., 2013; Henson et al., 2017; Kim et al., 2008; Meller et al., 2008; Kim et al., 2008) . Thus, in addition to their role in heterosynaptic and homosynaptic LTP of GPe-STN and cortico-STN transmission, respectively, STN NMDARs act as global activity sensors that regulate both the number and balance of GABAergic and glutamatergic synaptic inputs. Interestingly, the baseline density of cortico-STN axon terminals varied between the wild-type and transgenic and knockout mouse lines used in this study. The reasons are unclear but may reflect alterations to basal circuit activity produced by transgene expression or ion channel knockout.
Overall, our findings indicate that elevated cortico-STN correlation and coherence in PD are not due to strengthening of cortico-STN transmission. Abnormal GPe-STN transmission may, however, promote parkinsonian cortico-STN activity. GPe-STN inputs predominantly act at GABA A Rs and are sufficiently powerful and hyperpolarizing to synchronize STN activity (Baufreton et al., 2005) . GPe-STN inputs also de-inactivate postsynaptic Na v 1, Ca v 1, and Ca v 3 channels in STN neurons, which facilitates integration of subsequent excitatory synaptic transmission (Bevan et al., 2002; Baufreton et al., 2005) . Because cortico-STN and GPe-STN transmission are relatively phase offset following loss of dopamine (Mallet et al., 2008b) , an increase in the synchrony of GPe-STN firing (Mallet et al., 2008b) and transmission strength (Chu et al., 2015) should potently facilitate the response of STN neurons to cortical inputs (Baufreton et al., 2005) , despite their downregulation. Thus, an increase in synchronous activity and transmission strength in the indirect pathway may contribute to the abnormally correlated and coherent nature of cortico-STN activity in PD. Elucidating the relative impact of optogenetic or chemogenetic manipulation of cortico-STN neurons, D2-SPNs, or GPe-STN neurons on parkinsonian STN activity and associated motor dysfunction should help to resolve this issue.
The product of the frequency and amplitude of cortico-STN AMPAR-(this study; Table S1 ) and GPe-STN GABA A Rmediated (Chu et al., 2015;  (Table S3) , and (2) knockdown of STN NMDARs increased the ratio of cortical excitation to GPe inhibition approximately 3-fold and 14-fold in dopamine-intact and dopamine-depleted mice, respectively (Table S3 ). According to rate models of basal ganglia function and dysfunction (e.g., Albin et al., 1989) , the downregulation of cortico-STN synaptic transmission and upregulation of GPe-STN synaptic transmission in PD mice should be homeostatic in nature and oppose STN hyperactivity. However, knockdown of STN NMDARs, which massively increased the strength of synaptic excitation relative to inhibition (Chu et al., 2015) , ameliorated motor dysfunction in PD mice. It is conceivable that NMDAR knockdown was therapeutic because NMDAR-mediated patterning was eliminated, but this is unlikely given the dominant influence of AMPAR-mediated cortico-STN patterning. Thus, reduction of cortico-STN transmission strength relative to GPe-STN transmission in this model of mid-to late-stage PD appears to be maladaptive, and prevention of this shift is therapeutic. It remains to be determined whether prevention of hyperdirect pathway downregulation or disconnection of the indirect pathway or the combination of these effects contributes to improved motor function. Certainly, GPe-STN neurons appear to be critical for the expression of motor dysfunction, as evinced by the persistent therapeutic effect of their selective optogenetic stimulation in PD mice (Mastro et al., 2017) .
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: data randomly drawn from uniform distributions (runif() function in R). For Mann-Whitney tests, with a 50 percentile change in median between groups X and Y (the interquartile ranges of the groups don't overlap) P(Y > X) z0.88 giving an estimation that at least 10 observations per group would be needed to achieve 80% power; for a 25 percentile change (the median of Y falls outside the interquartile range of X) P(Y > X) z0.72 and the estimated requirement is at least 27 observations per group. For Wilcoxon tests, if all pairs of observations show the same direction of change, P(X + X' > 0) = 1 giving an estimation that at least 10 observations would be needed to achieve 80% power (note though that it is possible to show empirically that 6 observations gives 100% power in this case); if 90% of observations show the same direction of change, P(X + X' > 0) z0.98 and the estimated requirement is at least 12 pairs of observations.
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Original, processed, and analyzed data are available upon request. Sources of software are detailed in the Key Resources Table. 
